SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Skeeter Bug who wrote (29991)1/9/2000 12:29:00 AM
From: Henry Niman  Respond to of 32384
 
Speaking of labels, I just revisited the FDA site
fda.gov
and noticed that the CTCL label was for patients who had had one prior SYSTEMIC treatment.

Based on my read of the FDA comments, I think that Targretin will have even more off label use when it is prescribed as the FIRST systemic treatment.